Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Biologics (e.g., anifrolumab, belimumab) and targeted drugs (e.g., telitacicept, upadacitinib) both treat SLE, but network meta-analyses show telitacicept may outperform…
Patients with rheumatoid arthritis have a higher risk of shingles compared to the general population, with a pooled proportion of about 6% and a 30% increased risk.
Yes, Hadlima (adalimumab) is FDA-approved for treating moderately to severely active rheumatoid arthritis in adults.
Yes, sinomenine reduces arthritis markers in animal studies for rheumatoid arthritis, as shown by meta-analyses and individual rodent studies.
RNA methylation, especially m6A, is increased in rheumatoid arthritis and may drive synovitis by altering gene expression in joint cells, with potential as a biomarker and…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.